Clinical Trials Logo

Filter by:
NCT ID: NCT02916524 Recruiting - Aphasia Clinical Trials

Predicting Rehabilitation Outcomes in Bilingual Aphasia Using Computational Modeling

PROCoM
Start date: April 20, 2018
Phase: N/A
Study type: Interventional

The purpose of this investigation is to implement a computational model that can predict and optimize training and cross-language generalization patterns for bilingual persons with aphasia (BPA). The proposed work will determine the best possible treatment program for each individual patient even before they are rehabilitated. In addition, the computational model allows specification of variables such as age of acquisition, language exposure/proficiency, impairment and their systematic influence on a range of language rehabilitation outcomes.

NCT ID: NCT03474120 Recruiting - Clinical trials for Premature Ovarian Failure

Prospective Genetic Study in Patients With Ovarian Insufficiency

Start date: April 20, 2018
Phase:
Study type: Observational

genetic screening and etiological analysis was conducted on patients with ovarian insufficiency and decline in ovarian reserve. All patients were enrolled in the IVF-treated and non-IVF-treated groups, followed up for long-term treatment outcomes and genomic screening.

NCT ID: NCT03483792 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin

HERITOPK
Start date: April 20, 2018
Phase:
Study type: Observational

Polycystic ovary syndrome (PCOS) is the most common cause of ovulation disorders and affects 10 to 15% of women. Despite its frequency, its physiopathology remains unknown. In women, Anti-Müllerian hormone (AMH) is secreted by granulosa cells located in the ovaries within the follicles. Compared to control women, serum AMH level is higher in PCOS women and could play a role in its pathophysiology. The severity of the PCOS phenotype is correlated with the production of AMH. It is currently described in the literature that daughters of women with PCOS have a 50% risk of developing PCOS, but no genetic cause of transmission is known. In mice (article in press), pregnant females injected with AMH give birth to offspring with PCOS symptoms. The AMH could thus also play a role in the heritability of PCOS in women. Our team demonstrated that AMH, in its active cleaved form, had a direct central action on the hypothalamus by increasing the pulsatility of GnRH, inducing LH hypersecretion. The hypothesis is that AMH remains higher in pregnant women with PCOS and may affect the fetus by altering fetal and maternal hypothalamic secretions or by modifying placental steroid production. Leptin has a role in reproduction, through its receptors located at the central (hypothalamus) and peripheral (granulosa cells) levels. In excessively high serum concentration, as observed in obesity, it would lead to a dysregulation of GnRH secretion, an alteration of ovarian steroidogenesis and a dysregulation of folliculogenesis. Will be compare leptin levels in first trimester patients with and without PCOS to look for possible correlations between AMH and leptin and eliminate possible bias.

NCT ID: NCT03496402 Recruiting - Leukemia Clinical Trials

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

MICCHADO
Start date: April 20, 2018
Phase: N/A
Study type: Interventional

Methodology: Prospective, multicentric, open, non-randomised, non-therapeutic, interventional study

NCT ID: NCT03502356 Recruiting - Clinical trials for Randomized Controll Trial

Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.

Start date: April 20, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The good standard antibiotic prophylaxis pre elective C S is cefazolin and this study will approve addition of azithromycin to cefazolin will reduce post CS infections more than cefazolin only.

NCT ID: NCT03503331 Recruiting - Alzheimer Disease Clinical Trials

UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

PiB ADC
Start date: April 20, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to measure the concentration and the regional brain distribution of pathologic amyloid deposition using the PET tracer [C-11]PiB in participants in the UAB Alzheimer's Disease Center cohort. Assessment of interactions between race and vascular risk factors, brain amyloid levels measured with [C-11]PiB-PET, and cognitive status will be the primary outcome of this imaging study.

NCT ID: NCT03516162 Recruiting - Brain Tumor Clinical Trials

Linking Digital Smartphone Behaviour With Brain Function

SmartSurgery
Start date: April 20, 2018
Phase:
Study type: Observational

This study will thus examine daily behaviour based on smartphone use and link it to the neurological and neuropsychological status as well as to neuroradiological studies that are part of the clinical routine. The study will examine behaviour changes before and after surgery, and how this change in measured behaviour with the smartphone relates to today's "gold standard", namely professional neuropsychological examination and quantification of brain damage on imaging studies (MRI). This study is a proof-of-principle study that intends to build the basis for larger future observational studies on patients with focal or diffuse brain pathologies.

NCT ID: NCT03523897 Recruiting - Clinical trials for Primary Osteoarthritis of Knee Nos

A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes

Start date: April 20, 2018
Phase: N/A
Study type: Interventional

This study aims to see if outcomes for patients that receive the traditional total knee replacement surgical technique are different than the outcomes for patients that receive robot-assisted total knee replacement. The outcomes we will be tracking include: 1. Patients' self-reported awareness of their artificial joints during activities of daily living; 2. Patient's self-reported pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life; 3. Patients' self-reported general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy-fatigue, social functioning and mental health; 4. The accuracy of implant placement and limb alignment

NCT ID: NCT03554837 Recruiting - Atrial Fibrillation Clinical Trials

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

LEDIOS
Start date: April 20, 2018
Phase:
Study type: Observational

The efficacy and safety of edoxaban has not been adequately studied in Asians versus non-Asians, who are quite different physiologically from each other. Compared with non-East Asian patients, the East Asia patients were twice as likely to have the reasons for requiring dose reduction of edoxaban, such as CrCl 30-50 ml/min (30.0% and 18.2%, respectively), weight ≤60 kg (30.6% and 7.8%, respectively), or concomitant use of verapamil or quinidine (P-gp inhibitors, 6.6% and 3.3%, respectively). This study is aimed to evaluate the safety of the low dose edoxaban therapy in patients with high bleeding risk and non-valvular AF in the real world population of Korea.

NCT ID: NCT03695809 Recruiting - Clinical trials for Vulvar Cancer, G9a Protein

The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer

Start date: April 20, 2018
Phase:
Study type: Observational

To assess the G9a expression in vulvar cancer